다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Current therapeutic research, v.77, 2015년, pp.66 - 72
Rauš, Karel (Canadian Medical Care, Prague, Czech Republic) , Pleschka, Stephan (Institute of Medical Virology, Justus-Liebig-University Giessen, Giessen, Germany) , Klein, Peter (D.S.H. Statistical Services GmbH, Rohrbach, Germany) , Schoop, Roland (A. Vogel Bioforce AG, Roggwil, Switzerland) , Fisher, Peter (Royal London Hospital for Integrated Medicine, London, United Kingdom)
AI-Helper
BackgroundEchinacea has antiviral activity against influenza viruses in vitro and has traditionally been used for treatment of colds and flu.ObjectivesThis randomized, double-blind, double-dummy, multicenter, controlled clinical trial compared a new echinacea formulation with the neuraminidase inhib...
1 Fleming D.M. Elliot A.J. Nguyen-van Tam J.S. A winter’s tale: Coming to terms with winter respiratory illnesses 2005 Health Protection Agency London
2 Weber O. The role of viruses in the etiology and pathogenesis of common cold Eccles R.W.O. Common Cold 2009 Birkhäuser Verlag Basel, Switzerland 132 133
3 Call S.A. Vollenweider M.A. Hornung C.A. Does this patient has influenza? JAMA 293 2005 987 997 15728170
4 Nicholson K.G. Clinical features of influenza Semin Respir Infect 7 1992 26 37 1609165
5 Monto A.S. Gravenstein S. Elliott M. Clinical signs and symptoms predicting influenza infection Arch Intern Med 160 2000 3243 3247 11088084
6 Boivin G. Hardy I. Tellier G. Predicting influenza infections during epidemics with use of a clinical case definition Clin Infect Dis 31 2000 1166 1169 11073747
7 Guarner J. Paddock C.D. Shieh W.H. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season Clin Infect Dis 43 2006 132 140 16779738
8 Studahl M. Influenza virus and CNS manifestations J Clin Virol 28 2003 225 232 14522059
9 Jaimovich D.G. Kumar A. Shabino C.L. Formoli R. Influenza B virus infections associated with non-bacterial septic shock-like illness J Infect 25 1992 311 315 1474269
10 Cate T.R. Clinical manifestations and consequences of influenza Am J Medicine 82 1987 15 19
11 Reichert T.A. Simonsen L. Sharma A. Influenza and the winter increase in mortality in the United States, 1959-1999 Am J Epidemiol 160 2004 492 502 15321847
12 Nicholson K.G. Kent J. Hammersley V. Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study BMJ 313 1996 1119 1123 8916700
13 Treanor J.J. Hayden F.G. Vrooman P.S. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US oral Neuraminidase Study Group JAMA 283 2000 1016 1024 10697061
14 Aoki F.Y. Macleod M.D. Paggiaro P. IMPACT Study Group Early administration of oral oseltamivir increases the benefits of influenza treatment J Antimicrob Chemother 51 2003 123 129 12493796
15 Whitley R.J. Boucher C.A. Lina B. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS) Clin Infect Dis 56 2013 1197 1205 23307766
16 Jefferson T. Jones M.A. Doshi P. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children Cochrane Database Syst Rev 2014 4 CD008965
17 Pleschka S. Stein M. Schoop R. Hundson J.B. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV) Virol J 6 2009 197 19912623
18 Sharma M. Anderson S.A. Schoop R. Hudson J.B. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract Antiviral Res 83 2009 165 170 19409931
19 Sharma M. Schoop R. Hudson J.B. Echinacea as an anti-inflammatory agent: the influence of physiologically relevant parameters Phytother Res 23 2009 863 867 19107735
20 Ritchie M.R. Gertsch J. Klein P. Schoop R. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells Phytomedicine 18 2011 826 831 21726792
21 Colditz G.A. Miller J.N. Mosteller F. Measuring gain in the evaluation of medical technology: the probability of a better outcome Int J Technol Assess Health Care 4 1988 637 642 10291102
22 Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods Stat Med 17 1988 873 890 9595617
23 Kaiser L. Wat C. Mills T. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations Arch Internal Med 163 2003 1667 1672 12885681
24 Schanzer D.L. Garner M.J. Hatchette T.F. Estimating Sensitivity of Laboratory Testing for Influenza in Canada through Modelling PLoS ONE 4 2009 1 7
25 Jawad M. Schoop R. Suter A. Safety and efficacy profile of echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial Evid Based Complement Alternat Med 2012 841315 2012 23024696
26 Oh D.Y. Hurt A.C. A review of the antiviral susceptibility of human and avian influenza viruses over the last decade Scientifica (Cairo) 2014 430629 2014 24800107
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.